This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Mcneil Ab. Active years: 2010-2014.
Company Filing History:
Years Active: 2010-2014
Title: Folke Morén: Innovator in Pharmaceutical Formulations
Introduction
Folke Morén is a notable inventor based in Limhamn, Sweden. He has made significant contributions to the field of pharmaceutical formulations, particularly in the administration of nicotine for therapeutic purposes. With a total of 2 patents, Morén's work focuses on innovative methods to aid in the treatment of tobacco addiction.
Latest Patents
Morén's latest patents include formulations that provide liquid pharmaceutical solutions comprising nicotine for administration primarily to the lungs. These formulations are designed to be acidified and/or alkalized through buffering and/or pH regulation, allowing for a rapid increase of nicotine levels in the arterial blood of a subject after administration. The preferred method of administration involves spraying an aerosol into the oral cavity, facilitating further distribution into the lungs. Additionally, the patents disclose methods for manufacturing these formulations and their therapeutic uses, particularly in treating tobacco addiction.
Career Highlights
Throughout his career, Folke Morén has been associated with McNeil AB, where he has contributed to the development of innovative pharmaceutical solutions. His expertise in nicotine formulations has positioned him as a key figure in the industry, focusing on improving therapeutic outcomes for individuals struggling with tobacco addiction.
Collaborations
Morén has worked alongside talented colleagues, including Elisabeth Sthengel and Kristina Thyresson. Their collaborative efforts have further advanced the research and development of effective nicotine delivery systems.
Conclusion
Folke Morén's contributions to pharmaceutical innovations, particularly in nicotine formulations, highlight his commitment to improving public health. His work continues to influence the field and offers promising solutions for tobacco addiction treatment.